• Share
  • Email
  • Print

Olivia Lê Horovitz

Partner
+33.(0)1.58.44.15.27
Fax +33.(0)1.58.44.15.01

Ms. Olivia Lê Horovitz has extensive experience practicing corporate law and concentrates her practice on cross-border mergers and acquisitions as well as private equity transactions.

Olivia advises clients investing in Europe in a variety of complex multijurisdictional acquisition transactions. Her experience extends to the acquisition or sale of businesses, distressed companies, divestitures, spin-offs, recapitalizations, restructurings, negotiation of joint venture agreements and commercial contracts. Olivia advises public and private companies in a wide range of sectors primarily TMT, life sciences, healthcare and renewable energy. She also advises clients on environmental aspects of M&A transactions.

Olivia has represented both venture capital funds and corporate investors in their financing and acquisition activities at every stage of development, from initial financing rounds to disposals and liquidity transactions.

She is particularly active in the TMT, life science and renewable energy sectors.

Professional Background

Prior to joining K&L Gates, Ms. Lê Horovitz practiced as a partner in a reputable Paris law firm well known for its expertise in advising private equity funds and companies in the sectors of TMT and life sciences. She has previously worked for major Anglo-Saxon firms.

Mergers And Acquisitions / Corporate

Technology, Media and Telecom
  • Advising Microsoft Corporation on the acquisition of SyntaxTree, a French startup company creator of UnityVS plug-in for Visual Studio, one of the most heavily used tools in the gaming industry;

  • Advising Microsoft Corporation on its acquisition of Capptain S.A.S., a French company provider of CRM solutions to help mobile and web applications analyze user behavior and respond by pushing targeted messages;

  • Advising a US multinational online retailer on the acquisition of a French subsidiary of a digital comics company;

  • Advising 3D Systems Europe Ltd, a subsidiary of 3D Systems Corporation and leading global provider of 3D printing technology, on its acquisition of a significant majority of the share capital of Phenix Systems, a company listed on NYSE Alternext in Paris, leading provider of metal laser printers;

  • Advising 3D Systems Corporation on the acquisition of CoWeb, a French start up company that creates consumer customized 3D printed products and collectibles;

  • Advising 3D Systems Corporation on the acquisition of CEP and Protometal, two leading French rapid prototyping and manufacturer service providers;

  • Advising an American multinational conglomerate providing high technology products in the aerospace and building industries on the sale of its French industrial explosion protection business to a world leading explosion protection company. It was part of a global transaction which covered the United States, United Kingdom, Germany and Switzerland;

  • Advising a US broadcasting company on its contemplated acquisition of the French broadcasting leader company present in six jurisdictions in Europe;

  • Advising CapGemini on the acquisition of the French Order to Cash (OTC) business from Vengroff Williams & Associates;

  • Advising Avanex Inc. a leading U.S.-listed company providing intelligent photonic solutions and systems integrators with respect to the sale of 90 percent of Avanex France, its French subsidiary, to the managers after the spin off of part of its activities and with the implementation of a number of transitional commercial and IP agreements between the companies;

  • Advising Atex Group Ltd. a U.K. company providing mission critical software solutions to the media industry, on the acquisition of the French media business of Unisys Inc. employing more than 1500 people worldwide and providing media software solutions in more than 225 newspapers in 15 different countries;

  • Advising Aastra Technologies Ltd. a major listed Canadian company developing and marketing products and systems for accessing communication networks, on the acquisition of EADS Telecom telephony business;

  • Advising LSTelcom AG, a worldwide market leader in the provision of integrated spectrum management systems, on the acquisition of the spectrum management unit of CTS International;

  • Advising a consortium led by Access Industries, International Investment and Underwriting and Atlantic Bridge Ventures on the acquisition of LogicaCMG’s Telecom Products business which became Acision;

  • Advising Interface Data, integrator of management computer solutions for enterprises, on its sale to Prodware, an international integrator of IT solutions and Microsoft’s leading partner in the EMEA countries;

  • Advising OTI (On Track Innovation) an Israeli company listed on the Nasdaq being a global leader in contactless microprocessor-based smart card solutions, on the acquisition of 100% of the shares of Inseal, a French promising start up company specialized in providing operating systems for contactless applications as well as the acquisition of DXP / ID Parking, which has developed a payment system of rights due for parking;

  • Advising Cellon International a leading U.S. company (with presence in China and France) provider of end to end design and systems integration services for the wireless handset industry, with respect to the sale of its French subsidiary to the managers;

  • Advising Saving Point, an Israeli company specialized in providing costs reduction, on its sale to Alma Consulting Group;

  • Advising AT&T Wireless (Cingular) on the acquisition of Digicel, a Bahamas Corporation having interests in wireless licenses and telecommunications operations in the French West Indies and in France;

  • Advising Broadcom Corporation, a leading provider of highly integrated semiconductor solutions enabling broadband communication on the acquisition of Widcom Inc. leading provider of software solutions for Bluetooth wireless products.

Life Sciences / Healthcare
  • Advising a US generic and specialty pharmaceutical company, on its acquisition from one of the world leading pharmaceutical, chemical and life sciences company of the active pharmaceutical ingredient business and real estate assets in France;

  • Advising Degania Silicone Ltd, a leading Israel based OEM manufacturer of silicone based catheters and other devices, on the acquisition of Arthesys SAS, an original equipment manufacturer of stent delivery cardiovascular catheters;

  • Advising Biomarin, a US company developing and commercializing innovative biopharmaceuticals with respect to regulatory issues and negotiations of contracts for clinical trials;

  • Advising Covance, a biopharmaceutical development services company with preclinical and clinical research operations across the globe, on due diligence matters in view of the contemplated acquisition of Pfizer Global Research and Development toxicology & research facility located in Amboise;

  • Advising Protea entities with respect to a research and development agreement with French company, Laboratoires Mayoly Spindlers AS.

Energy
  • Advising Boralex Inc. (TSX: BLX), a renewable energy power producer, in connection with the acquisition of Enel Green Power France SAS from Enel Green Power SpA, Italy’s largest power company;

  • Advising Boralex Inc. on its acquisition of a 34.5 MW wind farm in operation from AES corporation as well as three wind projects of 56 MW installed capacity from Innovent SAS;

  • Advising Solaria Inc., a major U.S. solar supply company, with respect to the negotiation of the supply of photovoltaic modules to EDF Energie Renouvelable;

Other Sectors
  • Advising APPE France, the packaging and recycling division of La Seda de Barcelona, on the creation of a joint venture with Coca Cola Enterprises;

  • Advising Japanese and Indonesian leasing companies with respect to the French aspects of the acquisition and lease back transactions for aircrafts owned by the main French airline company;

  • Advising a US private equity fund traded on the NYSE and a Gibraltar based ship repair and conversion services, with respect to their offer to acquire the business of a French shipyard repair company under a bankruptcy proceeding;

  • Advising Boise Inc., a US paper and packaging company, on the acquisition of Hexacomb protective packaging business in France from Pregis Corporation;

  • Advising Teledyne Continental Motors Corporation on the acquisition of the aviation diesel piston engine technology and assets owned by SMA SA a subsidiary of Snecma, part of the Safran Group;

  • Advising Arkal Ltd, an Israeli agriculture company on the sale of its business to Elgo Europe;

  • Advising Eaton Corporation, the premier U.S. diversified industrial manufacturer of electrical systems and components for power systems, on the acquisition, of the French aerospace division of Fluid Science Perkinelmer, a U.S. company providing sealing and pneumatic systems for large commercial aircraft.

Private Equity Transactions

Technology, Media and Telecom
  • Advising Fondinvest Capital, a European leader in private equity fund to fund, on various purchase and sale of interests in several different funds;

  • Advising Apax France on the acquisition of Outremer Telecom the first telecom operator in the French Overseas Department;

  • Advising the investment funds of Travelprice (including Apax, Partech, Avenir Enterprises, AGF PE, Pictet & Cie), French online travel and leisure provider, with respect to the sale of all of their shares against listed shares of Lastminute.com online travel retailer;

  • Advising the management and Spef LBO (became Actem Partners) on the management buyout of Datavance Informatique, an IT service company;

  • Advising Avenir Entreprises (FCPR) on its investment in Datacet, specialized in security communication technology;

  • Advising Vizille Capital Innovation on its investment in Avilinks, designer of intelligent switches for broadband services;

  • Advising BV Capital, a Californian investment capital fund focused on the intersection of consumer internet, media and communications software investment, on its investment in Aelitis (Azureus Inc.) a French company providing an easy and cost effective way to distribute high quality media to very large audience, followed by the completion of a share exchange transaction (“flip”) of the French company into a U.S. company;

  • Advising Webraska investors (including Apax Partners, Aryo, GSM Capital and Cipio Partners), a French wireless navigation services company, with respect to its merger with Airflash Corporation, a provider of location based technologies and services;

  • Advising two investment funds MC Capital Europe and Spef Venture, on their investment into Streamcore a French company provider of intelligent traffic management solutions and then representing all the investment funds and managers of this company, with respect to their exit through a share exchange transaction with Boostworks Inc. a U.S. company publisher of software solutions to accelerate fluidity of traffic;

  • Advising the investment funds - Partech International, Innovacom, CIC Capital Privé, Turenne Capital, Rothschild Investment Partners, Pictet, FCJE, FD5 - and managers of Right Vision, expert in internet services solutions aimed at middle size enterprises (information and communication technology) with respect to their exit through a share exchange transaction with Alcatel, a French listed company world leader of telecom equipment provider;

  • Advising Valoris investment funds shareholders, a management consultant firm in business intelligence and CRM, on their sale to Sopra Group. Valoris shareholders include Apax, Altamir, Morgan Stanley Venture, Rothschild Gestion;

  • Advising GIMV and AGF Private Equity, with respect to their investment in Cril Telecom Software, a leading supplier of IT solutions for the telecommunication industry.

Life Sciences / Healthcare
  • Advising the French FCJCE biotech fund of the Caisse des Dépôts et Consignations on several due diligences in view of investment in biotech companies, including Urogene and OTL Pharma;

  • Advising Apax Partners on their investment in DrugAbuse Sciences SAS, first bio pharmaceutical company focused on developing therapies for treatment of substance abuse;

  • Advising Clal Biotechnologies Industries, Israeli leading investor in life sciences, on its investment in IDM Immuno Designed Molecules SA French.

Energy

  • Advising Boralex Inc. in establishing a European partnership with Cube Infrastructure Fund in Luxembourg for raising € 33 million equity financing to accelerate its development in Europe.